Siesta Life Sciences And Drugs Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 16-07-2024
- Paid Up Capital ₹ 1.00 M
as on 16-07-2024
- Company Age 17 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 6.00 M
as on 16-07-2024
- Revenue -56.53%
(FY 2023)
- Profit 351.92%
(FY 2023)
- Ebitda 11.99%
(FY 2023)
- Net Worth 4.61%
(FY 2023)
- Total Assets 17.83%
(FY 2023)
About Siesta Life Sciences And Drugs
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹6.00 M.
Vikram Deora and Smrithi Deora serve as directors at the Company.
- CIN/LLPIN
U24232RJ2007PTC024202
- Company No.
024202
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Apr 2007
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Jaipur
Industry
Company Details
- Location
Udaipur, Rajasthan, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Siesta Life Sciences And Drugs?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vikram Deora  | Director | 13-Apr-2007 | Current |
| Smrithi Deora | Director | 13-Apr-2007 | Current |
Financial Performance of Siesta Life Sciences And Drugs.
Siesta Life Sciences And Drugs Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 56.53% decrease. The company also saw a substantial improvement in profitability, with a 351.92% increase in profit. The company's net worth moved up by a moderate rise of 4.61%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Siesta Life Sciences And Drugs?
In 2022, Siesta Life Sciences And Drugs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 27 May 2015 | ₹3.00 M | Open |
Hdfc Bank Limited Creation Date: 08 Dec 2010 | ₹3.00 M | Open |
How Many Employees Work at Siesta Life Sciences And Drugs?
Unlock and access historical data on people associated with Siesta Life Sciences And Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Siesta Life Sciences And Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Siesta Life Sciences And Drugs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
